HYOEN JOO LEE: Open Payments
NPI 1871859926 · TIMONIUM, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$707 in 28 payments from 17 companies in 2025. Trend: 2023 $688 · 2024 $987 · 2025 $707
Food & beverage: $707
| Company | Payments | Amount |
|---|---|---|
| Corcept Therapeutics | 4 | $200 |
| SANOFI-AVENTIS U.S. LLC | 2 | $63 |
| RECORDATI_RARE_DISEASES_INC. | 3 | $58 |
| ABBVIE INC. | 3 | $54 |
| Novo Nordisk Inc | 2 | $42 |
| Radius Health, Inc. | 2 | $34 |
| Tandem Diabetes Care, Inc. | 1 | $32 |
| Lilly USA, LLC | 2 | $29 |
| Amgen Inc. | 1 | $26 |
| Novartis Pharmaceuticals Corporation | 1 | $26 |
Products named: Korlym, TZIELD, ISTURISA, t:slim X2 Insulin Pump with Control-IQ, SYNTHROID, MOUNJARO, TEPEZZA, LEQVIO.
Industry payments across MD — which companies pay providers there.
